Target intelligence / Profile preview

MicroRNA 3174 (miR-3174)

Target
miR-3174
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 3174 (miR-3174) is a short (20–24 nucleotide) non-coding RNA that mediates post-transcriptional regulation of gene expression via the RNA-induced silencing complex. It functions as a tumor suppressor in several cancer types, particularly glioblastoma, where it inhibits cell proliferation, induces apoptosis, and reduces invasion by repressing the expression of multiple tumor-promoting genes. miR-3174 is typically downregulated in cancerous tissues compared to normal tissues, and its restoration may have therapeutic potential. As a microRNA, it belongs to a class of regulatory RNAs, not to traditional therapeutic target families like receptors or enzymes, but is directly implicated in the control of key cancer-related pathways.

Other names
hsa-mir-3174MIR3174hsa-miR-3174
02

Mechanism of action

Binds to target mRNAs, leading to translational inhibition or degradation of the target mRNA. Downregulates tumor-promoting genes such as CD44, MDM2, RHOA, PLAU, and CDK6 in glioblastoma.

03

Biological functions

Post-transcriptional regulation of gene expressionInhibition of cell proliferationInduction of apoptosisSuppression of tumor growthInhibition of cell invasion
04

Disease associations

Cancer (notably glioblastoma, endometrial cancer, gastric cancer, bladder cancer, breast cancer, rectal cancer, and hepatocellular carcinoma)
05

Safety considerations

None specifically reported, but as a microRNA, challenges may include off-target effects and delivery in therapeutic contexts
06

Biomarkers

Downregulated miR-3174 expression may serve as a biomarker for glioblastoma and potentially other cancers

Beyond the preview

Go deeper on MicroRNA 3174 (miR-3174).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3174 (miR-3174).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call